216
Cancer of the Prostate: Molecular Genetics
instability,
Cancer
Genet.
Cytogenet.
61
,
165–173.
Miet, S.M., Neyra, M., Jaques, R., et al. (1999)
RER(
+
) phenotype in prostate intra-epithelial
neoplasia associated with human prostate-
carcinoma development,
Int. J. Cancer
82
,
635–639.
Millar, D.S., Ow, K.K., Paul, C.L., et al. (1999)
Detailed
methylation
analysis
of
the
glutathione S-transferase pi (GSTP1) gene in
prostate cancer,
Oncogene
18
, 1313–1324.
Monroe, K.R.,
Yu, M.C.,
Kolonel, M.N.,
et al.
(1995) Evidence of an X linked or recessive
genetic component to prostate cancer risk,
Nat. Med.
1
, 827–829.
Morin, G.B.
(1989)
The
human
telomere
transferase
is
a
ribonucleoprotein
that
synthesizes
TTAGGG
repeats,
Cell
59
,
521–529.
Morton, D.M., Barrack, E.R. (1995) Modulation
of transforming growth factor beta 1 effects
on prostate cancer cell proliferation by growth
factors and extracellular matrix,
Cancer Res.
55
,
2596–2602.
Morton,
R.A.,
Ewing,
C.M.,
Watkins,
J.J.,
Isaacs, W.B. (1995) The E-cadherin cell-cell
adhesion pathway in urologic malignancies,
World J. Urol.
13
, 364–368.
Morton, R.A.,
Watkins, J.J.,
Bova, G.S.,
et al.
(1996) Hypermethylation of chromosome 17P
locus D17S5 in human prostate tissue,
J. Urol.
156
, 512–516.
Moul, J.W., Friedrichs, P.A., Lance, R.S., et al.
(1992) Infrequent Ras oncogene mutations in
human prostate cancer,
Prostate
20
, 327–338.
Multani, A.S.,
Ozen, M.,
Agrawal, A.,
et al.
(1999) Ampli±cation of the Y chromsome in
three murine tumor cell lines transformed
in
vivo
by different human prostate cancers,
In
Vitro Cell Dev. Biol. Anim.
35
, 236–239.
Nag, A.,
Smith, R.G.
(1989)
Ampli±cation,
rearrangement, and elevated expression of c-
myc in the human prostatic carcinoma cell
line LNCaP,
Prostate
15
, 115–122.
Nagle, R.B., Hao, J.S., Knox, J.D., et al. (1995)
Expression of hemidesmosomal and extracel-
lular matrix proteins by normal and malignant
human prostate tissue,
Am. J. Pathol.
146
,
1498–1507.
Narod, S.A., Dupont, A., Cusan, L., et al. (1995)
The impact of family history on early detection
of prostate cancer,
Nat. Med.
1
, 99–101.
Natali, P.G.,
Nicotra, M.R.,
Bigotti, A.,
et al.
(1990) Expression of the p185 encoded by
HER2 oncogene in normal and transformed
human tissues,
Int. J. Cancer
45
, 457–461.
Nelson, J.B.,
Lee, W.H.,
Nguyen, S.H.,
et al.
(1997) Methylation of the 5
0
CpG island of
the endothelin B receptor gene is common in
human prostate cancer,
Cancer Res.
57
,35–37.
Noordzij, M.A., vanSteenbrugge, G.-J., Verkaik,
N.S., et al. (1997) The prognostic value of CD44
isoforms in prostate cancer patients treated
by radical prostatectomy,
Clin. Cancer Res.
3
,
805–815.
O’Connor, P.M., Jackman, J., Jondle, D., et al.
(1993) Role of the p53 tumor suppressor
gene in cell cycle arrest and radiosensitivity
of Burkitt’s lymphoma cell lines,
Cancer Res.
53
, 4776–4780.
Paradis, V., Dargere, D., Laurendeau, I., et al.
(1999) Expression of the RNA component of
human telomerase (hTR) in prostate cancer,
prostatic intraepithelial neoplasia, and normal
prostate tissue.,
J. Pathol.
189
, 213–218.
P
a
r
s
o
n
s
,
R
.
,L
i
,
G
.
M
.
,L
o
n
g
l
e
y
,
M
.
J
.
,e
t
a
l
.
(1993) Hypermutability and mismatch repair
de±ciency in RER
+
tumor cells,
Cell
75
,
1227–1236.
Platz, E.A., Giovannucci, E., Dahl, D.M., et al.
(1998) The androgen receptor gene GGN
microsatellite and prostate cancer risk,
Cancer
Epidemiol. Biomarkers Prev.
7
, 379–384.
Prendergast, N.J.,
Atkins, M.R.,
Schatte, E.C.,
et al.
(1996)
p53
immunohistochemical
and
genetic
alterations
are
associated
at
high incidence with post-irradiated locally
persistent prostate carcinoma,
J. Urol.
155
,
1685–1692.
Prendergast, N.J., Walther, P.J. (1995) Genetic
alterations in prostate adenocarcinoma,
Surg.
Oncol. Clin. North Am.
4
, 241–255.
Qian, J.,
Bostwick, D.G.,
Takahashi, S.,
et al.
(1995) Chromosomal anomalies in prostatic
intraepithelial
neoplasia
and
carcinoma
detected by fluorescence in situ hybridization,
Cancer Res.
55
, 5408–5414.
Rabinovitz, I., Nagle, R.B., Cress, A.E. (1996)
Integrin alpha 6 expression in human prostate
carcinoma cells is associated with a migratory
and invasive phenotype
in vitro
and
in vivo
,
Clin. Exp. Metastasis
13
, 481–491.
Rahman,
M.M.,
Miyamoto,
H.,
Lardy, H.,
Chang, C. (2003) Inactivation of androgen
receptor coregulator ARA55 inhibits androgen
receptor
activity
and
agonist
effect
of
antiandrogens in prostate cancer cells,
Proc.
Natl. Acad. Sci. U.S.A.
100
(9), 5124–5129.
previous page 890 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 892 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off